107 related articles for article (PubMed ID: 514938)
1. Left ventricular failure with labetalol.
Frais MA; Bayley TJ
Postgrad Med J; 1979 Sep; 55(646):567-8. PubMed ID: 514938
[TBL] [Abstract][Full Text] [Related]
2. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
3. Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.
Adam WR; Meagher EJ; Barter CE
Clin Exp Hypertens A; 1982; 4(8):1419-28. PubMed ID: 6126285
[TBL] [Abstract][Full Text] [Related]
4. Vascular symptoms in patients with primary Raynaud's phenomenon are not exacerbated by propranolol or labetalol.
Steiner JA; Cooper R; Gear JS; Ledingham JG
Br J Clin Pharmacol; 1979 Apr; 7(4):401-3. PubMed ID: 375960
[No Abstract] [Full Text] [Related]
5. Cutaneous reaction to labetalol.
Branford WA; Hunter JA; Muir AL
Practitioner; 1978 Nov; 221(1325):765-7. PubMed ID: 154093
[No Abstract] [Full Text] [Related]
6. Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension.
Hansson L; Hänel B
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):763-4. PubMed ID: 10952
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hypertension with labetalol.
Bolli P; Waal-Manning HJ; Simpson FO; Seeman HM
N Z Med J; 1977 Dec; 86(602):557-63. PubMed ID: 306082
[TBL] [Abstract][Full Text] [Related]
8. Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.
Besterman EM; Spencer M
Br J Clin Pharmacol; 1979; 8(Suppl 2):205S-209S. PubMed ID: 526402
[TBL] [Abstract][Full Text] [Related]
9. Beta-adrenergic blocking agents. Effect of chronic dosage on a fit, middle-aged man: a case study and review.
Steinrauf LK; Schulz AR; Ryder KW; Brunn PW; Cook D; Judy W
Indiana Med; 1985 Jul; 78(7):600-4. PubMed ID: 2863304
[No Abstract] [Full Text] [Related]
10. Labetalol. Current research and therapeutic status.
Wallin JD; O'Neill WM
Arch Intern Med; 1983 Mar; 143(3):485-90. PubMed ID: 6338850
[TBL] [Abstract][Full Text] [Related]
11. A pilot trial of labetalol (AH 5158A): a combined alpha and beta blocker in treatment of hypertension.
Dent R; Kellaway GS
N Z Med J; 1977 Sep; 86(595):213-5. PubMed ID: 305013
[TBL] [Abstract][Full Text] [Related]
12. Labetalol in long-term treatment of hypertension.
Prichard BN; Boakes AJ
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):743-50. PubMed ID: 62582
[TBL] [Abstract][Full Text] [Related]
13. Labetalol.
Carter BL
Drug Intell Clin Pharm; 1983 Oct; 17(10):704-12. PubMed ID: 6354658
[TBL] [Abstract][Full Text] [Related]
14. Labetalol in resistant hypertension.
Dargie HJ; Dollery CT; Daniel J
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):751-5. PubMed ID: 990154
[TBL] [Abstract][Full Text] [Related]
15. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
Thompson FD; Joekes AM; Hussein MM
Br J Clin Pharmacol; 1979; 8(Suppl 2):129S-133S. PubMed ID: 526392
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of hypertension with labetalol.
Erichs M; Rothgardt NP; Andersson E
Postgrad Med J; 1980; 56 Suppl 2():53-6. PubMed ID: 7433343
[TBL] [Abstract][Full Text] [Related]
17. Labetalol-induced toxic myopathy.
Teicher A; Rosenthal T; Kissin E; Sarova I
Br Med J (Clin Res Ed); 1981 Jun; 282(6279):1824-5. PubMed ID: 6786636
[TBL] [Abstract][Full Text] [Related]
18. Labetalol for hypertension.
Med Lett Drugs Ther; 1984 Sep; 26(670):83-5. PubMed ID: 6147747
[No Abstract] [Full Text] [Related]
19. Synergism between halothane and labetalol.
Hunter JM
Anaesthesia; 1979 Mar; 34(3):257-9. PubMed ID: 378019
[TBL] [Abstract][Full Text] [Related]
20. Side-effects with long-term labetalol: an open study of 251 patients in a single centre.
Tcherdakoff P
Pharmatherapeutica; 1983; 3(5):342-8. PubMed ID: 6844370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
